Concepedia

Christopher M. Boswell

CM

Statistics

Publications

6

Citations

594

H-Index

6

Active since

1992

Affiliations

The Christie NHS Foundation Trust(Current)

Christopher M. Boswell is an author at The Christie NHS Foundation Trust specializing in immunology, vaccination, and preventive vaccination.

Publications per year

1992–2003

6

Publications

6

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

Andreas M. Kaufmann, Peter L. Stern, Elaine M. Rankin et al. · PubMed · 2002 · 204 citations

, , +17

Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.

Peter Baldwin, Sjoerd H. van der Burg, Christopher M. Boswell et al. · PubMed · 2003 · 174 citations

, , +17

Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.

Emma J. Davidson, Christopher M. Boswell, Peter Sehr et al. · PubMed · 2003 · 171 citations

, , +17

Avidity maturation, repertoire shift, and strain differences in antibodies to bacterial levan, a type 2 thymus-independent polysaccharide antigen

Christopher M. Boswell, K E Stein · The Journal of Immunology · 1996 · 20 citations · Full text

, , +17

Strain-dependent restricted VH and VL usage by anti-bacterial levan monoclonal antibodies

Christopher M. Boswell, Diana Irwin, Joanne Goodnight et al. · The Journal of Immunology · 1992 · 13 citations · Full text

, , +14

1–5 of 6